NUBEQA (darolutamide) 300 mg tablets logo NUBEQA (darolutamide) 300 mg tablets logo
STAY CONNECTED
NUBEQA (darolutamide) 300 mg tablets logo NUBEQA (darolutamide) 300 mg tablets logo
STAY CONNECTED

Español

POSSIBLE SIDE EFFECTS

Icon of a conversation between a healthcare professional and a patient

Knowledge is power.

The information below may help you talk to your doctor about:

  • Side effects that are possible with NUBEQA®
  • Symptoms to watch out for
  • Actions to take if you experience side effects

NUBEQA may cause serious side effects, including:

Heart disease - Blockage of the arteries in the heart (ischemic heart disease) that can lead to death has happened in some people during treatment with NUBEQA. Your healthcare provider will monitor you for signs and symptoms of heart problems during your treatment with NUBEQA. Call your healthcare provider or get medical help right away if you get chest pain or discomfort at rest or with activity, or shortness of breath during your treatment with NUBEQA.

Seizure - Treatment with NUBEQA may increase your risk of having a seizure. You should avoid activities where a sudden loss of consciousness could cause serious harm to yourself or others. Tell your healthcare provider right away if you have loss of consciousness or seizure during treatment with NUBEQA.

Most common side effects of NUBEQA

Icon of a liver with an upward arrow

Increase in liver function tests

Measuring liver enzyme levels can tell your doctor if your liver is working properly.

Icon of drop with the letter W and a down arrow

Decreased white blood cells (neutropenia)

Low levels of white blood cells
can raise your risk of infections.

Monitoring

These side effects may not have any symptoms. Your care team will monitor you through blood tests, and explain results to you.

Icon of a person seated at a desk with a tired symbol

Feeling more tired
than usual

Management

Talk to your care team. They may recommend certain everyday movement and light exercise.

    The most common side effects of NUBEQA in combination with docetaxel include:
    • Constipation
    • Rash
    • Decreased appetite
    • Bleeding
    • Weight gain
    • High blood pressure
    • High blood sugar levels
    • Decreased red blood cells (anemia)
    • Decreased white blood cells
    • Increase in liver function tests
    • Low blood calcium levels

    NUBEQA may cause fertility problems in males, which may affect their ability to father children. Talk to your healthcare provider if you have concerns about fertility. 

    These are not all the possible side effects of NUBEQA. 

    Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 

    *ADT refers to a medical or surgical treatment that lowers testosterone.

    In the non-metastatic prostate cancer study, notable side effects that occurred in 2% or more men who took NUBEQA included ischemic heart disease (4%) and heart failure (2.1%). In the metastatic prostate cancer study that did not include chemotherapy, notable side effects that occurred in less than 10% of men who took NUBEQA included arrhythmia (8.8%), pneumonia (3.6%), and myocardial infarction (0.7%). In the metastatic prostate cancer study that included chemotherapy, notable side effects that occurred in less than 10% of patients who received NUBEQA with docetaxel included fractures (8%), ischemic heart disease (3.2%), seizures (0.6%), and drug-induced liver injury (0.3%).

    Your doctor may change your dose, temporarily stop, or completely stop your treatment with NUBEQA if you have certain side effects.

    Explore additional tolerability data

    See results from clinical trials See results from
clinical trials

    Hand holding pills icon

    See treatment results from clinical trials with NUBEQA

    NUBEQA + ADT (with or without chemotherapy) for metastatic prostate cancer

    See the results See the results

    NUBEQA for
non-metastatic
prostate cancer

    See the results See the results

    Talk to your doctor

    Remember that your doctor is there to help manage your treatment, including any side effects that may occur.

    Non-metastatic results
    Additional Tolerability Data

    Important Safety Information

    Important Safety Information

    Before taking NUBEQA, tell your healthcare provider about all your medical conditions, including if you:

    • have heart problems, high blood pressure, diabetes, or high amounts of fat or cholesterol in your blood (dyslipidemia)
    • have a history of seizures, brain injury, stroke, or brain tumors
    • have kidney or liver problems
    • are pregnant or plan to become pregnant. NUBEQA can cause harm to your unborn baby and loss of pregnancy (miscarriage)
    • have a partner who may become pregnant. Males who have female partners who may become pregnant should use effective birth control (contraception) during treatment and for 1 week after the last dose of NUBEQA. Talk with your healthcare provider about birth control methods
    • are breastfeeding or plan to breastfeed. It is not known if NUBEQA passes into breast milk

    Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. NUBEQA may affect the way other medicines work and other medicines may affect how NUBEQA works.

    You should not start or stop any medicine before you talk with the healthcare provider that prescribed NUBEQA.

    Know the medicines you take. Keep a list of them with you to show to your healthcare provider and pharmacist when you get a new medicine.

    NUBEQA may cause serious side effects, including:

    • Heart disease. Blockage of the arteries in the heart (ischemic heart disease) that can lead to death has happened in some people during treatment with NUBEQA. Your healthcare provider will monitor you for signs and symptoms of heart problems during your treatment with NUBEQA. Call your healthcare provider or get medical help right away if you get chest pain or discomfort at rest or with activity, or shortness of breath during your treatment with NUBEQA.
    • Seizure. Treatment with NUBEQA may increase your risk of having a seizure. You should avoid activities where a sudden loss of consciousness could cause serious harm to yourself or others. Tell your healthcare provider right away if you have loss of consciousness or seizure during treatment with NUBEQA.

    The most common side effects of NUBEQA include:

    • increase in liver function tests
    • decreased white blood cells (neutropenia)
    • feeling more tired than usual

    The most common side effects of NUBEQA in combination with docetaxel include:

    • constipation
    • rash
    • decreased appetite
    • bleeding
    • weight gain
    • high blood pressure
    • decreased red blood cells (anemia)
    • high blood sugar levels
    • decreased white blood cells
    • increase in liver function tests
    • low blood calcium levels

    NUBEQA may cause fertility problems in males, which may affect the ability to father children. Talk to your healthcare provider if you have concerns about fertility.

    These are not all the possible side effects of NUBEQA.

    Call your healthcare provider for medical advice about side effects. You are encouraged to report side effects or quality complaints of products to the FDA by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088.

    Please see the full Prescribing Information.

    <span>WHAT IS NUBEQA<sup>®</sup>?</span>

    WHAT IS NUBEQA®?

    NUBEQA® (darolutamide) is a prescription medicine used to treat adults with prostate cancer:

    • that has not spread to other parts of the body and no longer responds to a medical or surgical treatment that lowers testosterone
    • that has spread to other parts of the body and responds to a medical or surgical treatment that lowers testosterone
    • that has spread to other parts of the body and responds to a medical or surgical treatment that lowers testosterone in combination with docetaxel.

    It is not known if NUBEQA is safe and effective in females or children.

    © 2026 Bayer. All rights reserved. BAYER, the Bayer Cross and NUBEQA are registered trademarks of Bayer, and Access Services by Bayer is a trademark of Bayer.

    Date of last update: 9/17/2026